Fig. 3From: An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trialsThe relationships of operating characteristics and sample sizes of gBOIN and gBOINS when the target toxicity rates are 20% and 30%. The two pictures on the left panel, only one dose lying inside (0.16,0.24) and (0.24,0.36) respectively for the top and bottom panel; on the right panel, there are two doses lying inside their corresponding intervalsBack to article page